000 01498 a2200421 4500
005 20250517064147.0
264 0 _c20170106
008 201701s 0 0 eng d
022 _a1029-2330
024 7 _a10.3109/1061186X.2015.1113539
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Che
245 0 0 _aMelanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
_h[electronic resource]
260 _bJournal of drug targeting
_c2016
300 _a548-56 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnnexin A5
_xmetabolism
650 0 4 _aAntimicrobial Cationic Peptides
_xpharmacology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aCircular Dichroism
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMice
650 0 4 _aPhosphatidylserines
_xmetabolism
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aStatic Electricity
700 1 _aChen, Yin-Wang
700 1 _aZhang, Liang
700 1 _aGong, Xian-Ge
700 1 _aZhou, Yang
700 1 _aShang, De-Jing
773 0 _tJournal of drug targeting
_gvol. 24
_gno. 6
_gp. 548-56
856 4 0 _uhttps://doi.org/10.3109/1061186X.2015.1113539
_zAvailable from publisher's website
999 _c25475611
_d25475611